Histopathological findings in two cases of torsade de pointes with conduction disturbances

Torsades de pointes in a case of hypertrophic cardiomyopathy with special reference to the pathologic findings of the heart including the conduction system

A clinicopathologic study was performed in a 77-year-old female with hypertrophic cardiomyopathy who had experienced recurrent syncopal attacks due to Torsades de Pointes (TdP) following QT prolongation and atrioventricular block. She died suddenly two years later while eating dinner. Pathologic findings of the heart showed a dilated and hypertrophied left ventricle. The heart weighed 550 g. There were two foci of localized endocardial fibroelastosis (EFE) beneath the aortic valve, one with a size of 3.5 x 3.5 cm, and the other (2 x 1 cm) located on the upper ventricular septum. Histologic findings showed hypertrophy and disarray in the left ventricular myocardium. The conduction system using serial sectioning revealed remarkable bilateral bundle branch fibrosis and hypertrophied Purkinje fibers in the left bundle branch adjacent to the EFE on the ventricular septum. These findings were thought to be related to the occurrence of TdP.

Anatomy, histology, and pathology of the cardiac conduction system--Part III

The cardiac conduction system may be affected by various pathologic changes. Some of these changes are general and affect the nonconduction system tissues of the heart (atrophy, fibrosis, necrosis, segment deposition, mineral) and others are more localized to the conduction system (Lev and Lenegre disease). Pathologic conditions associated with atrial, junctional, and ventricular arrhythmias are reviewed.

Torsades de pointes: atypical rhythm, atypical treatment

For the present, treatment of the acquired Torsades de Pointes consists of removal of the causative agent, correction of the underlying electrolyte imbalance, and initiation of direct therapy. Unresponsive dysrhythmias may need magnesium therapy or cardioversion.

Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients

The clinical setting, precipitating factors, electrocardiographic features and response to treatment of 32 patients with torsade de pointes were reviewed. Thirty-one patients had underlying cardiac disease and 30 patients had a previous underlying cardiac arrhythmia. Antiarrhythmic medications, often in association with electrolyte abnormalities (such as hypokalemia and hypomagnesemia) were the most common precipitating factors. In 22 of 26 patients, the serum drug levels of the antiarrhythmic agents were found to be within the therapeutic range. However, before the administration of agents known to prolong the QT interval, 20 of the 32 patients had, either alone or in combination, baseline prolongation of the QT interval, hypokalemia or hypomagnesemia. All patients had QTc interval prolongation (mean 0.59 second) immediately before the development of torsade de pointes. Marked lability of T wave morphology was frequently noted. Cardiac pacing was the only consistently effective mode of therapy. A characteristic long-short ventricular cycle length as the initiating sequence was found in 41 of 44 episodes of torsade de pointes. Reported data support the high frequency of this electrocardiographic feature of torsade de pointes in which its onset could be analyzed. It is suggested that this electrocardiographic characteristic will aid in both establishing the diagnosis of torsade de pointes and distinguishing it from other polymorphic forms of ventricular tachycardia.

Pathologic changes in the cardiac conduction and nervous system in sudden coronary death

The arrhythmogenic substrates for sudden coronary death were studied in 13 autopsied hearts and in 2 left stellate ganglia (surgically excised). Diffuse or segmentary obstruction of nutritional arteries accounted for acute ischemic injury of the conduction system, which was the underlying cause of high-risk bradycardic arrhythmias in one-third of the cases. However, in one-quarter of the cases the survival of anoxia-resistant subendocardial specialized fibers was probably responsible for reentrant lethal tachycardic arrhythmias. In other cases, early infarct damage could have fatal arrhythmias of either type. Intrinsic and/or extrinsic neuropathologic changes, unbalancing the autonomic action on the heart, were often seen to participate in the arrhythmogenic features of sudden coronary death.

Torsade de pointes

Torsade de pointes is a distinct electrocardiographic entity, characterized by a periodic undulation of the ventricular complex (QRS) around an imaginary line, simulating a cardiac ballet. It usually manifests in patients with abnormalities of repolarization, as evidenced on the surface electrocardiogram by a prolonged ventricular recovery (QT) interval and may degenerate into a fatal ventricular fibrillation following use of conventional antiarrhythmic agents. Therapy includes correction of the underlying cause, overdrive pacing, and isoproterenol infusion.

Polymorphous ventricular tachycardia: clinical features and treatment

Thirty-four cases of ventricular tachyarrhythmia characterized by polymorphy of the QRS complexes with changing R-R intervals and a heart rate of 150 to 300 beats/min, termed polymorphous ventricular tachycardia, are described. The factors involved in the appearance of this arrhythmia were the administration of antiarrhythmic drugs (quinidine 22 patients, procainamide 5 patients, ajmaline 1 patient), antianginal drugs (prenylamine [Synadrin] 4 patients) and antidepressant drugs (thioridazine 1 patient). Twenty-one patients were treated for premature ventricular complexes, three for chronic recurrent ventricular tachycardia, six for atrial flutter and fibrillation, three for anginal pain and one patient for mental depression. All patients except one had a drug-induced prolonged corrected Q-T interval before the appearance of polymorphous ventricular tachycardia. Most of the patients with this arrhythmia were considered to have severe myocardial disease. Lidocaine and electric cardioversion were administered to all patients, but were effective only in seven patients whose tachycardia occurred in short, single episodes. The most effective treatment (17 patients) was temporary ventricular pacing at rates ranging from 100 to 140 beats/min. Intravenous isoproterenol proved to be successful in another 10 cases. It is concluded that patients with severe myocardial involvement receiving antiarrhythmic drugs for premature ventricular complexes, especially the multiform variety, are at high risk for the development of polymorphous ventricular tachycardia.